FDA Inspection 1127880 — National Institute for Allergy and Infectious Diseases (NIAID)

National Institute for Allergy and Infectious Diseases (NIAID) — FEI 3012863122

The FDA completed an inspection of National Institute for Allergy and Infectious Diseases (NIAID) on August 14, 2020 in Rockville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 14, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Rockville, MD (United States)

Additional Details

Sponsor, Contract Research Organization